6-{[(1R,2S)-2-Aminocyclohexyl]amino}-5-cyano-2-(3-methylanilino)pyridine-3-carboxamide

ID: ALA4457164

PubChem CID: 69284028

Max Phase: Preclinical

Molecular Formula: C20H24N6O

Molecular Weight: 364.45

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cccc(Nc2nc(N[C@@H]3CCCC[C@@H]3N)c(C#N)cc2C(N)=O)c1

Standard InChI:  InChI=1S/C20H24N6O/c1-12-5-4-6-14(9-12)24-20-15(18(23)27)10-13(11-21)19(26-20)25-17-8-3-2-7-16(17)22/h4-6,9-10,16-17H,2-3,7-8,22H2,1H3,(H2,23,27)(H2,24,25,26)/t16-,17+/m0/s1

Standard InChI Key:  XAMCCSYNPOEISO-DLBZAZTESA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
    4.3611  -18.5023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3599  -19.3219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0680  -19.7308    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7776  -19.3214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7748  -18.4987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0662  -18.0935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6533  -18.0939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6531  -17.2767    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9456  -18.5027    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6519  -19.7299    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6512  -20.5471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9431  -20.9536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9421  -21.7700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6500  -22.1800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3604  -21.7676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3579  -20.9525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4860  -19.7289    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4873  -20.5461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7772  -20.9509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7765  -21.7646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4831  -22.1759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1920  -21.7674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1943  -20.9476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9011  -20.5375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2339  -22.1777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4787  -18.0863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1849  -17.6750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  7  8  1  0
  7  9  2  0
  2 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  4 17  1  0
 18 17  1  1
 18 19  1  0
 18 23  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  1
 13 25  1  0
 26 27  3  0
  5 26  1  0
M  END

Associated Targets(Human)

FER Tclin Tyrosine-protein kinase FER (2362 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 364.45Molecular Weight (Monoisotopic): 364.2012AlogP: 2.79#Rotatable Bonds: 5
Polar Surface Area: 129.85Molecular Species: BASEHBA: 6HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.30CX Basic pKa: 9.92CX LogP: 3.99CX LogD: 1.59
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.65Np Likeness Score: -1.16

References

1. Taniguchi T, Inagaki H, Baba D, Yasumatsu I, Toyota A, Kaneta Y, Kiga M, Iimura S, Odagiri T, Shibata Y, Ueda K, Seo M, Shimizu H, Imaoka T, Nakayama K..  (2019)  Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity.,  10  (5): [PMID:31097992] [10.1021/acsmedchemlett.8b00631]

Source